emetine has been researched along with Cancer of Lung in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Li, D; Teng, X; Wang, K; Zhang, C; Zhang, K | 1 |
| Hayase, R; Ichikawa, Y; Ito, A; Kondoh, Y; Maemoto, Y; Noritsugu, K; Ogawa, K; Osada, H; Sekine, S; Takase, S; Yoshida, M | 1 |
| Chang, H; Chang, SY; Huang, TW; Lin, YW; Shih, YL; Wu, TH | 1 |
| Konrad, S; Kühnel, A; Multhoff, G; Schilling, D; Tetzlaff, F | 1 |
| Cho, EB; Cho, JY; Jung, O; Kim, JH; Kim, SH; Lee, J; Lee, SY; Ryou, C; Ryu, BJ | 1 |
| DEMICHELE, D; FINELLI, L; GAMBARDELLA, A | 1 |
| Boon-Unge, K; Govitrapong, P; Yu, Q; Zhou, A; Zhou, J; Zou, T | 1 |
| Gabathuler, R; Jefferies, WA; Kolaitis, G | 1 |
| Lund, LR | 1 |
| Street, EW | 1 |
| Hyde, KR; Marsh, K; Perry, W | 1 |
| Auphan, D; Ferro, R; Gourul, JC; Perquis, P; Varieras, G | 1 |
| Coltman, CA; Panettiere, F | 1 |
13 other study(ies) available for emetine and Cancer of Lung
| Article | Year |
|---|---|
Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.
Topics: Adenocarcinoma of Lung; Computational Biology; COVID-19 Drug Treatment; DNA-Binding Proteins; Emetine; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Molecular Docking Simulation; SARS-CoV-2; Serotonin Plasma Membrane Transport Proteins; Transcription Factors | 2022 |
Identification of a derivative of the alkaloid emetine as an inhibitor of the YAP-TEAD interaction and its potential as an anticancer agent.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Emetine; Humans; Lung Neoplasms; TEA Domain Transcription Factors; Transcription Factors; YAP-Signaling Proteins | 2023 |
Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Emetics; Emetine; Humans; Lung Neoplasms; Neoplasm Proteins; Tumor Cells, Cultured | 2019 |
NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cytotoxicity, Immunologic; DNA-Binding Proteins; Emetine; Female; Gene Expression Regulation, Neoplastic; Heat Shock Transcription Factors; Histocompatibility Antigens Class I; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Killer Cells, Natural; Lung Neoplasms; Lymphocyte Activation; NF-kappa B; NK Cell Lectin-Like Receptor Subfamily K; Resorcinols; RNA Interference; RNA, Small Interfering; Sp1 Transcription Factor; Transcription Factors | 2015 |
Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways.
Topics: beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Emetine; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Targeted Therapy; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-myc; Signal Transduction | 2015 |
[COLLIQUATIVE AMEBIC HAPITITIS, WITH SECONDARY PULMONARY ABSCESS. ASSOCIATED CHLOROQUINE-EMETINE TREATMENT. RECOVERY].
Topics: Abscess; Chloroquine; Emetine; Geriatrics; Liver Abscess; Liver Abscess, Amebic; Lung Abscess; Lung Neoplasms | 1963 |
Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
Topics: Alternative Splicing; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Down-Regulation; Emetine; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Marine Toxins; Okadaic Acid; Oxazoles; Prostatic Neoplasms; Protein Phosphatase 1; Protein Phosphatase 2; Up-Regulation; Uterine Cervical Neoplasms | 2007 |
IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
Topics: Animals; Antigen-Presenting Cells; Antigens, Viral; beta 2-Microglobulin; Brefeldin A; Cyclopentanes; Cytotoxicity, Immunologic; Emetine; Histocompatibility Antigens Class I; Immunity, Cellular; In Vitro Techniques; Interferon-gamma; Lung Neoplasms; Mice; Mice, Inbred C57BL; Peptides; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured; Vesicular stomatitis Indiana virus | 1993 |
Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Topics: Anisomycin; Cell Line; Cycloheximide; Dose-Response Relationship, Drug; Emetine; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lung Neoplasms; Protein Synthesis Inhibitors; Puromycin; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Rhabdomyosarcoma; RNA, Messenger; RNA, Neoplasm; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1996 |
Cyclophosphamide plus emetine in lung cancer.
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Combinations; Emetine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiography; Remission, Spontaneous | 1972 |
Cyclophosphamide plus emetine in lung cancer.
Topics: Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Emetine; Humans; Lung Neoplasms; Male; Middle Aged | 1972 |
[Amebic abscess of the right lower lobe of the lung with tumoral aspects. Diagnostic and therapeutic problems].
Topics: Adult; Amebiasis; Diagnosis, Differential; Emetine; Humans; Liver Abscess, Amebic; Lung Abscess; Lung Diseases, Parasitic; Lung Neoplasms; Male; Pleurisy; Pneumonectomy; Radiography | 1973 |
Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Colonic Neoplasms; Diarrhea; Electrocardiography; Emetine; Female; Humans; Injections, Intravenous; Laryngeal Neoplasms; Leukemia, Lymphoid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Myositis; Nausea; Tachycardia; Thyroid Neoplasms; Tracheal Neoplasms; Urinary Bladder Neoplasms | 1971 |